Functional Decline in Older Patients With Cancer Receiving First-Line ChemotherapyHOPPE, Stéphanie; RAINFRAY, Muriel; VOGT, Luc et al.Journal of clinical oncology. 2013, Vol 31, Num 31, pp 3877-3882, issn 0732-183X, 6 p.Article

First-Line Chemotherapy of Disseminated Germ Cell TumorsNICHOLS, Craig; KOLLMANNSBERGER, Christian.Hematology/oncology clinics of North America. 2011, Vol 25, Num 3, issn 0889-8588, viii, 543-556 [15 p.]Article

Immunoglobulin treatment in primary antibody deficiencyMAARSCHALK-ELLERBROEK, L. J; HOEPELMAN, I. M; ELLERBROEK, P. M et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 5, pp 396-404, issn 0924-8579, 9 p.Article

Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: A dose escalation studyBONNETERRE, Jacques; TUBIANA-HULIN, Michèle; CATIMEL, Gilles et al.Oncology. 2004, Vol 66, Num 3, pp 185-191, issn 0030-2414, 7 p.Article

Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian PatientsTOSTMANN, Alma; MTABHO, Charles M; SEMVUA, Hadija H et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3208-3213, issn 0066-4804, 6 p.Article

Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for CancerSOUBEYRAN, Pierre; FONCK, Marianne; ANDRIAMAMPIONONA, Francis et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1829-1834, issn 0732-183X, 6 p.Article

The Interface of Primary and Oncology Specialty Care: From Diagnosis Through Primary TreatmentSUSSMAN, Jonathan; BALDWIN, Laura-Mae.Journal of the National Cancer Institute. Monographs. 2010, Vol 40, pp 18-24, issn 1052-6773, 7 p.Article

The Interface Between Primary and Oncology Specialty Care: Treatment Through SurvivorshipGRUNFELD, Eva; EARLE, Craig C.Journal of the National Cancer Institute. Monographs. 2010, Vol 40, pp 25-30, issn 1052-6773, 6 p.Article

Front-line immunosuppressive treatment of acquired aplastic anemia : Treatment and Hematopoietic Stem Cell Transplantation in Aplastic AnemiaDUFOUR, C; SVAHN, J; BACIGALUPO, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 174-177, issn 0268-3369, 4 p.Article

Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. CommentaryGUILHOT, Francois; HEHLMANN, Rüdiger; REITER, Andreas et al.Blood. 2007, Vol 109, Num 11, issn 0006-4971, 4592, 4686-4692 [8 p.]Article

Front-Line Treatment in Younger Patients With Multiple MyelomaVINCENT RAJKUMAR, S; SONNEVELD, Pieter.Seminars in hematology. 2009, Vol 46, Num 2, pp 118-126, issn 0037-1963, 9 p.Article

Video-assisted thoracoscopic surgery as a first-line treatment for mediastinal parathyroid adenomas: strategic value of imagingAMAR, L; GUIGNAT, L; TISSIER, F et al.European journal of endocrinology. 2004, Vol 150, Num 2, pp 141-147, issn 0804-4643, 7 p.Article

Treating Patients With EGFR-Sensitizing Mutations: First Line or Second Line—Is There a Difference?MOK, Tony; YANG, Jin-Ji; LAM, Kwok-Chi et al.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1081-1088, issn 0732-183X, 8 p.Article

Traitement de première ligne chez le sujet âgéDARTIGEAS, C.Correspondances en onco-hématologie. 2009, Num JUIL, pp 12-15, issn 1954-4820, 4 p., NSArticle

Cyanoacrylic glue : A minimally invasive nonsurgical first line approach for the treatment of some urinary fistulasMUTO, Giovanni; D'URSO, Leonardo; CASTELLI, Emanuele et al.The Journal of urology. 2005, Vol 174, Num 6, pp 2239-2243, issn 0022-5347, 5 p.Article

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancerRIEMSMA, Rob; FORBES, C. A; KESSELS, A et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 9-24, issn 0167-6806, 16 p.Article

Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?JIAN ZHANG; GU, Shi-Yang; YU GAN et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 103-113, issn 0344-5704, 11 p.Article

The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patientsHOCHHAUS, Andreas; KANTARJIAN, Hagop.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 12, pp 1971-1984, issn 0171-5216, 14 p.Article

Long-Term Efficacy and Safety of Arsenic Trioxide for First-Line Treatment of Elderly Patients With Newly Diagnosed Acute Promyelocytic LeukemiaYINGMEI ZHANG; ZHUO ZHANG; YING ZHANG et al.Cancer. 2013, Vol 119, Num 1, pp 115-125, issn 0008-543X, 11 p.Article

Initiation of hypertension treatment with a fixed-dose combination or its monocomponents : does it really matter?SCHOLZE, J; BIDA, M; HANSEN, A et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 3, pp 265-274, issn 1368-5031, 10 p.Article

Will Focal Therapy Remain Only an Attractive Illusion for the Primary Treatment of Prostate Cancer?GIANNARINI, Gianluca; GANDAGLIA, Giorgio.Journal of clinical oncology. 2014, Vol 32, Num 13, pp 1299-1301, issn 0732-183X, 3 p.Article

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future DirectionsGONZALEZ-MARTIN, Antonio; SANCHEZ-LORENZO, Luisa; BRATOS, Raquel et al.Drugs (Basel). 2014, Vol 74, Num 8, pp 879-889, issn 0012-6667, 11 p.Article

Ruxolitinib for the treatment of primary myelofibrosisSWAIM, Starla J.American journal of health-system pharmacy. 2014, Vol 71, Num 6, pp 453-462, issn 1079-2082, 10 p.Article

Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infectionsQUIST, S. R; FIERLBECK, G; SEATON, R. A et al.International journal of antimicrobial agents (Print). 2012, Vol 39, Num 1, pp 90-91, issn 0924-8579, 2 p.Article

Impact of First-Line Antifungal Agents on the Outcomes and Costs of CandidemiaYOUNG EUN HA; KYONG RAN PECK; JOO, Eun-Jeong et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3950-3956, issn 0066-4804, 7 p.Article